These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 11602256
1. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. De Petrocellis L, Davis JB, Di Marzo V. FEBS Lett; 2001 Oct 12; 506(3):253-6. PubMed ID: 11602256 [Abstract] [Full Text] [Related]
2. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L. Biochem J; 2001 Aug 15; 358(Pt 1):249-55. PubMed ID: 11485574 [Abstract] [Full Text] [Related]
3. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V. Fundam Clin Pharmacol; 2002 Aug 15; 16(4):297-302. PubMed ID: 12570018 [Abstract] [Full Text] [Related]
4. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ. Br J Pharmacol; 2002 Jun 15; 136(3):452-8. PubMed ID: 12023948 [Abstract] [Full Text] [Related]
5. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. Vandevoorde S, Lambert DM, Smart D, Jonsson KO, Fowler CJ. Bioorg Med Chem; 2003 Mar 20; 11(6):817-25. PubMed ID: 12614867 [Abstract] [Full Text] [Related]
6. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V. Br J Pharmacol; 2001 Oct 20; 134(4):845-52. PubMed ID: 11606325 [Abstract] [Full Text] [Related]
7. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V. J Neurochem; 2001 Jun 20; 77(6):1660-3. PubMed ID: 11413249 [Abstract] [Full Text] [Related]
8. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355 [Abstract] [Full Text] [Related]
9. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V. J Biol Chem; 2001 Apr 20; 276(16):12856-63. PubMed ID: 11278420 [Abstract] [Full Text] [Related]
10. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, Mercuri NB. J Neurosci; 2003 Apr 15; 23(8):3136-44. PubMed ID: 12716921 [Abstract] [Full Text] [Related]
11. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V. Cell Mol Life Sci; 2003 Mar 15; 60(3):607-16. PubMed ID: 12737320 [Abstract] [Full Text] [Related]
12. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, Cairns W, Hayes PD, Randall AD, Davis JB. Eur J Pharmacol; 2001 Apr 06; 417(1-2):51-8. PubMed ID: 11301059 [Abstract] [Full Text] [Related]
13. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D. Br J Anaesth; 2002 Dec 06; 89(6):882-7. PubMed ID: 12453933 [Abstract] [Full Text] [Related]
14. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB. Br J Pharmacol; 2000 Jan 06; 129(2):227-30. PubMed ID: 10694225 [Abstract] [Full Text] [Related]
15. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Roberts LA, Christie MJ, Connor M. Br J Pharmacol; 2002 Oct 06; 137(4):421-8. PubMed ID: 12359623 [Abstract] [Full Text] [Related]
16. Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. McQueen DS, Bond SM, Smith PJ, Balali-Mood K, Smart D. Eur J Pharmacol; 2004 May 03; 491(2-3):181-9. PubMed ID: 15140635 [Abstract] [Full Text] [Related]
17. Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Tóth A, Kedei N, Wang Y, Blumberg PM. Life Sci; 2003 Jun 13; 73(4):487-98. PubMed ID: 12759142 [Abstract] [Full Text] [Related]
18. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM. Br J Pharmacol; 2004 Apr 13; 141(7):1118-30. PubMed ID: 15006899 [Abstract] [Full Text] [Related]
19. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Ho WS, Barrett DA, Randall MD. Br J Pharmacol; 2008 Nov 13; 155(6):837-46. PubMed ID: 18695637 [Abstract] [Full Text] [Related]
20. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V. J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]